Skip to main content
Clinical Trials/NCT03046108
NCT03046108
Unknown
Phase 4

Comparison Between Blind and Ultrasound Guided Injection in Morton Neuroma

Complejo Hospitalario Universitario de Granada1 site in 1 country100 target enrollmentJanuary 2016

Overview

Phase
Phase 4
Intervention
blind injection of Morton neuroma
Conditions
Morton Neuroma
Sponsor
Complejo Hospitalario Universitario de Granada
Enrollment
100
Locations
1
Primary Endpoint
Pain (VAS score)
Last Updated
8 years ago

Overview

Brief Summary

The aim of this work trial is to compare the effectiveness of blind and ultrasound guided injection for Morton neuroma in order to determine which is more appropriate as the initial procedure in conservative treatment

Detailed Description

This is a evaluator-blinded randomized trial. The final sample size has been calculated to be 100 patients. 50 of group 1 are going to be injected by an experimented orthopaedic surgeon based on anatomic landmark. 50 of group 2 are going to be injected by an experimented musculoskeletal radiologist under ultrasound guidance. The inclusion criteria are clinical suspicion of Morton neuroma confirmed in ultrasound scan. Included patients are assessed clinically by VAS score, the Manchester Foot Pain and Disability Schedule (MFPDS), and a generic quality-of-life instrument, the EQ-5D. Injection includes 1 cc of 2% mepivacaine and 40 mg of triamcinolone in each web space with Morton Neuroma. According evolution until 4 injections were allowed the first 2 months of follow-up, Follow up was performed by phone calls and/or scheduled consultations at 15 days, 1 month, 45 days, 2 months, 3 months, 6 months and 1 year. Statistical analysis was performed by unpaired Student's t test

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
August 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Complejo Hospitalario Universitario de Granada
Responsible Party
Principal Investigator
Principal Investigator

FERNANDO RUIZ SANTIAGO

PhD, section chief musculoskeletal radiology

Complejo Hospitalario Universitario de Granada

Eligibility Criteria

Inclusion Criteria

  • Clinical suspicion of Morton neuroma confirmed in ultrasound scan
  • Symptoms present more than six months
  • The thickness of the nerve must be at least 2 mm in short axis and at least 5 mm in the longitudinal axis.

Exclusion Criteria

  • Contraindication for the use of corticosteroids or local anesthetics
  • Presence of inflammatory arthropathy or neuropathy
  • Skin lesions in the area
  • diabetes mellitus
  • Infiltration or previous surgery in the area
  • Refusal to participate in the study

Arms & Interventions

blind injection of Morton neuroma

Percoutaneous blind injection in Morton neuroma by subcutaneous needle group 1 are going to be injected by an experimented orthopaedic surgeon based on anatomic landmark. There is no internal control of the needle placement. Mixture of 1 cc of 2% mepivacaine (Mepivacaina Normon 2%® )+ 40 mg of triamcinolone (Trigon Depot®) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: blind injection of Morton neuroma

blind injection of Morton neuroma

Percoutaneous blind injection in Morton neuroma by subcutaneous needle group 1 are going to be injected by an experimented orthopaedic surgeon based on anatomic landmark. There is no internal control of the needle placement. Mixture of 1 cc of 2% mepivacaine (Mepivacaina Normon 2%® )+ 40 mg of triamcinolone (Trigon Depot®) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: blind injection of Mepivacaine

blind injection of Morton neuroma

Percoutaneous blind injection in Morton neuroma by subcutaneous needle group 1 are going to be injected by an experimented orthopaedic surgeon based on anatomic landmark. There is no internal control of the needle placement. Mixture of 1 cc of 2% mepivacaine (Mepivacaina Normon 2%® )+ 40 mg of triamcinolone (Trigon Depot®) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: blind injection of Triamcinolone

blind injection of Mepivacaine

1 cc of 2% mepivacaine (Mepivacaina Normon 2%® )+ 40 mg of triamcinolone (Trigon Depot®) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: blind injection of Morton neuroma

blind injection of Mepivacaine

1 cc of 2% mepivacaine (Mepivacaina Normon 2%® )+ 40 mg of triamcinolone (Trigon Depot®) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: blind injection of Mepivacaine

blind injection of Mepivacaine

1 cc of 2% mepivacaine (Mepivacaina Normon 2%® )+ 40 mg of triamcinolone (Trigon Depot®) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: blind injection of Triamcinolone

blind injection of Triamcinolone

40 mg of triamcinolone (Trigon Depot®) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: blind injection of Morton neuroma

blind injection of Triamcinolone

40 mg of triamcinolone (Trigon Depot®) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: blind injection of Mepivacaine

blind injection of Triamcinolone

40 mg of triamcinolone (Trigon Depot®) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: blind injection of Triamcinolone

ultrasound guided injection

US guided injection in Morton neuroma by subcutaneous needle. group 2 are going to be injected by an experimented musculoskeletal radiologist under ultrasound guidance. There is internal control of needle placement by ultrasound.

Intervention: ultrasound guided injection

ultrasound guided injection

US guided injection in Morton neuroma by subcutaneous needle. group 2 are going to be injected by an experimented musculoskeletal radiologist under ultrasound guidance. There is internal control of needle placement by ultrasound.

Intervention: guided injection of mepivacaine

ultrasound guided injection

US guided injection in Morton neuroma by subcutaneous needle. group 2 are going to be injected by an experimented musculoskeletal radiologist under ultrasound guidance. There is internal control of needle placement by ultrasound.

Intervention: guided injection of Triamcinolone

guided injection of mepivacaine

2% mepivacaine (Mepivacaina Normon 2%® ) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: ultrasound guided injection

guided injection of mepivacaine

2% mepivacaine (Mepivacaina Normon 2%® ) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: guided injection of mepivacaine

guided injection of mepivacaine

2% mepivacaine (Mepivacaina Normon 2%® ) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: guided injection of Triamcinolone

guided injection of Triamcinolone

40 mg of triamcinolone (Trigon Depot®) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: ultrasound guided injection

guided injection of Triamcinolone

40 mg of triamcinolone (Trigon Depot®) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: guided injection of mepivacaine

guided injection of Triamcinolone

40 mg of triamcinolone (Trigon Depot®) in each of the web spaces affected with Morton neuroma is injected. Up to 4 injections are allow in the first three months of follow-up

Intervention: guided injection of Triamcinolone

Outcomes

Primary Outcomes

Pain (VAS score)

Time Frame: 1 year

Pain relieve

Secondary Outcomes

  • Manchester foot pain and disability index(1 year)
  • Generic quality-of-life instrument, the EQ-5D(1 year)

Study Sites (1)

Loading locations...

Similar Trials